Virpax Pharmaceuticals

Virpax Pharmaceuticals Highlights Leadership Contributions at Clinical Trial Conference

BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced that Matthew Barnes, the company’s senior director of portfolio management, will be presenting at the Outsourcing in Clinical Trials (OCT) Conference. …

Virpax Pharmaceuticals Highlights Leadership Contributions at Clinical Trial Conference Read More